A Phase 4 interventional study of ramipril 5 mg + valsartan 80 mg/day, and ramipril 10 mg + valsartan 160 mg/day, in Heavy Proteinuria, sponsored by Nantes University Hospital. Terminated at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2009-02-04.
Sponsored by Nantes University Hospital · Phase 4 and Interventional
Determine the best strategy for proteinuria lowering in patients with proteinuria > 1 g/day receiving ACEI and ARB combination: either increase of ACEI and ARB dosage or increase of diuretic dosage.
234 studies on the registry are indexed under Proteinuria; 43 are open to participants now.
This study's enrollment of 18 is below the median of 60 across 164 interventional studies indexed under Proteinuria.
Browse Proteinuria studies →Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
This study is terminated, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nantes University Hospital